CIPLA
|
The Current P/E Ratio of CIPLA is 23.89.
Share Price | ₹1,479.4 | Jan 31,2025 |
Market Cap | ₹119,472.3 Cr | |
Earnings-TTM | ₹5,000.4 Cr | TTM-Consolidated Results |
Price/Earnings | 23.89x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of CIPLA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹119,472.3 Cr] as on Jan 31,2025
(/) Earnings [ ₹5,000.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 23.89x ]
Thus, for CIPLA , the investors are currently willing to pay 23.89 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CIPLA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of CIPLA over the last five years.
Historical PE (Price/Earnings) ratio chart of CIPLA
PE Ratio Performance Analysis for CIPLA
- CIPLA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 27.45x.
- CIPLA 's operated at median p/e ratio of 27.34x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/e ratio peaked in Mar2022 at 32.65x.
- CIPLA 's p/e ratio hit its five-year low in Mar2020 of 22.05x.
How does CIPLA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
CIPLA | 5,000.43 | 23.89 | 119,472.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.41 | 418,228.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.72 | 101,599.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.70 | 97,604.7 |
DIVIS LABORATORIES LTD | 1,836.00 | 80.62 | 148,023.0 |
MANKIND PHARMA LTD | 2,050.73 | 49.03 | 100,540.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 59.24 | 110,306.0 |
LUPIN LTD | 2,651.94 | 35.82 | 94,984.6 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.91 | 68,055.4 |
ABBOTT INDIA LTD | 1,284.66 | 43.25 | 55,558.7 |
ALKEM LABORATORIES LTD | 2,160.96 | 28.01 | 60,525.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CIPLA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.72x |
Max industry PE | 80.62x |
Median industry PE | 35.82x |
Average industry PE | 37.87x |
You may also like the below Video Courses